1 April 2022 in Journal of Applied Physiology
Many individuals with end-stage osteoarthritis (OA) undergo elective total hip/knee arthroplasty (THA/TKA) to relieve pain, improve mobility and quality of life. However, ∼30% suffer long-term mobility impairment following surgery. This may be in part due to muscle inflammation susceptibility (MuIS+), an overt proinflammatory pathology localized to skeletal muscle surrounding the diseased joint, present in some patients with TKA/THA. We interrogated the hypothesis that MuIS+ status results in a perturbed perioperative gene expression profile and decreases skeletal muscle integrity in patients with end-stage OA. Samples were leveraged from the two-site, randomized, controlled trial R01HD084124, NCT02628795. Participants were dichotomized based on surgical (SX) muscle gene expression of TNFRSF1A (TNF-αR). MuIS+/− samples were probed for gene expression and fibrosis. Paired and independent two-tailed t tests were used to determine differences between contralateral (CTRL) and surgical (SX) limbs and between-subject comparisons, respectively. Significance was declared at P < 0.05. Seventy participants (26M/44F; mean age 62.41 ± 8.86 yr; mean body mass index 31.10 ± 4.91 kg/m2) undergoing THA/TKA were clustered as MuIS+ (n = 24) or MuIS− (n = 46). Lower skeletal muscle integrity (greater fibrosis) exists on the SX versus CTRL limb (P < 0.001). Furthermore, MuIS+ versus MuIS− muscle exhibited higher proinflammatory (IL-6R and TNF-α) and catabolic (TRIM63) gene expression (P < 0.001, P = 0.004, and 0.024 respectively), with a trend for greater fibrosis (P = 0.087). Patients with MuIS+ exhibit more inflammation and catabolic gene expression in skeletal muscle of the SX limb, accompanied by decreased skeletal muscle integrity (Trend). This highlights the impact of MuIS+ status emphasizing the potential value of perioperative MuIS assessment to inform optimal postsurgical care. NEW & NOTEWORTHY This study assessed the skeletal muscle molecular characteristics associated with end-stage osteoarthritis and refined an important phenotype, in some patients, termed muscle inflammation susceptibility (MuIS+) that may be an important consideration following surgery. Furthermore, we provide evidence of differential inflammatory and catabolic gene expression between the contralateral and surgical limbs along with differences between the skeletal muscle surrounding the diseased hip versus knee joints.
1 September 2025 in Physiological Genomics
We examined in vivo and ex vivo adaptations to traditional moderate-intensity endurance and resistance training (TRAD) versus high-intensity tactical training (HITT; explosive whole-body interval training and high-intensity resistance training). TRAD and HITT improved physiological performance and body composition, and induced ex vivo muscle adaptations, with remarkable interindividual response heterogeneity (IRH) in improvements. We leveraged multidimensional modeling to identify interindividual response heterogeneity biocircuitry that integrates deep phenotyping and miR transcriptomics (serum exosomes and skeletal muscle).
21 August 2025 in Journal of Applied Physiology
We showed higher resistance training (RT) volume (4-sets) offsets muscle hypertrophy non-responsiveness to single-set RT (1-set), while enhancing hypertrophic response among responders. Here, we investigated molecular traits underpinning RT-related hypertrophic variability via targeted (ribosome density and biogenesis) and untargeted approaches (RNAseq gene-ontology (GO) and Pathway-Level Information ExtractoR [PLIER]). Twenty-seven older (693 years) participants in the parental trial had one leg randomly allocated to 1-set and the contralateral leg allocated to 4-sets of RT for 10-wk, 2x/week. Pre- and postintervention, participants underwent magnetic resonance imaging (MRI) and muscle biopsies. We selected participants based on quadriceps muscle cross-sectional area (qCSA) changes and used the MRI typical error (2xTE=3.27%) to allocate those in distinct hypertrophy phenotype: low-responders: blunted hypertrophy, regardless of RT-volume; medium-responders: hypertrophy only following the higher RT-volume; and high-responders: hypertrophy following both RT-volume. The qCSA was higher for 4-sets compared with 1-set for medium- and high-responders only. Higher RT-volume, regardless of responsiveness groups, was followed by increased Frizzled-1 protein expression. RNAseq showed that high-responder‘s robust hypertrophy was followed by up-regulation of pathways linked with protein turnover metabolism, RT-related metabolic response, and with protein-folding biological processes. Hypertrophy in medium-responders was marked by down-regulation of pathways linked with muscle catabolism (Proteasome and Spliceosome), modulations on distinct RT-related metabolic response, and biological processes associated with hormone- and steroid-related pathways. Low-responders, on the other hand, did not show measurable changes in any molecular pathways, regardless of RT volume manipulation. Overall, these finding reveal differential molecular signatures across the spectrum of RT responsiveness among older individuals.
20 January 2025 in medRxiv
In a randomized, dose-response trial, we used molecular and phenomic profiling to compare responses to traditional (TRAD) moderate intensity endurance and resistance training vs. high-intensity tactical training (HITT) that encompassed explosive whole-body interval training and high-intensity resistance training. Ninety-four participants (18-27 years) completed 12 weeks of TRAD or HITT followed by 4 weeks of detraining. Although similar performance and body composition improvements were observed in response to HITT and TRAD, some dose-dependent differences were observed for: (i) ex vivo muscle tissue changes in myofiber size, capillarization, satellite cell frequency, and mitochondrial function; and (ii) differential gene expression (DGE) of muscle and serum exosomal miRNAs (miRs). However, these dose-dependent ex vivo muscle adaptations were overshadowed by wide-ranging inter-individual response heterogeneity (IRH). We therefore explored IRH by first establishing minimum clinically important difference (MCID) scores to classify each participant based on MCIDs for functional muscle quality (fMQ) and cardiorespiratory fitness (CRF), and then modeling all data based on MCID classification. Using higher-order singular value decomposition (HOSVD), we established multidimensional biocircuitry linked to IRH that identified the most influential features across lifestyle, body composition, performance, ex vivo muscle tissue, and miRNA mapping domains. Via cross-comparison of MCID-linked miRs identified via DGE and HOSVD, nine miRs emerged as robust features of training adaptability, providing new insights into the integrated biocircuitry driving IRH. NEW & NOTEWORTHY: We examined in vivo and ex vivo adaptations to TRAD (traditional moderate-intensity endurance and resistance training) vs. HITT (high-intensity tactical training; explosive whole-body interval training and high-intensity resistance training). TRAD and HITT improved physiological performance and body composition, and induced ex vivo muscle adaptations, with remarkable inter-individual response heterogeneity (IRH) in improvements. We leveraged multidimensional modeling to identify IRH biocircuitry that integrates deep phenotyping and miR transcriptomics (serum exosomes, skeletal muscle).
1 November 2025 in Journal of Applied Physiology
The Multidimensional Modeling to Maximize Adaptations to eXercise (M 3 AX) Trial is the first trial designed specifically to better understand interindividual response heterogeneity (IRH) among older adults during combined endurance and resistance training. A two-phase sequential multiple assignment randomized trial design (enrolling n = 250) enables IRH interrogation in Phase I (12 wk) and mitigation in Phase II (10 wk), with deep phenotyping across physiological, metabolic, cognitive, behavioral, cellular, and molecular domains including biological hallmarks of aging.